Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerecor Inc (NQ: AVTX )

3.890 -0.090 (-2.26%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45,783
Open 3.440
Bid (Size) 3.810 (5)
Ask (Size) 4.270 (2)
Prev. Close 3.980
Today's Range 3.430 - 4.025
52wk Range 2.423 - 11.88
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants
From Avalo Therapeutics
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga

Performance

YTD
-22.36%
-22.36%
1 Month
-24.32%
-24.32%
3 Month
-42.63%
-42.63%
6 Month
-2.14%
-2.14%
1 Year
-63.61%
-63.61%

More News

Read More
Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
From Avalo Therapeutics
Via Globe NewsWire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Looking Into Avalo Therapeutics's Return On Capital Employed
Via Benzinga
Recap: Avalo Therapeutics Q3 Earnings
Via Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Avalo Announces it Has Completed Targeted Enrollment of 80 Patients in Phase 2 PEAK Trial of AVTX-002 in Non-Eosinophilic Asthma
From Avalo Therapeutics
Via Globe NewsWire
Avalo Therapeutics, Apollo Therapeutics Ink Pact For Anti-IL-18 Antibody
Via Benzinga
Avalo Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Avalo Therapeutics
Via Globe NewsWire
Avalo Sells Economic Rights to Previously Out-Licensed Assets for $5 Million
From Avalo Therapeutics
Via Globe NewsWire
Avalo Therapeutics Earnings Perspective: Return On Capital Employed
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Avalo Therapeutics' Shares Climb Following Patient Dosing in Immunodeficiency Disorder Study
Via Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Via Benzinga
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
5 Short Squeeze Candidates To Watch This Week: Singing Machine And Revlon Top The List, Chicken Soup For Soul Rejoins
Via Benzinga
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Surges 250 Points; Crude Oil Rises Sharply
Via Benzinga
Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue
Via Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Via Benzinga
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.